# Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis

> **NCT02280096** · PHASE2 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 24 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** 4-aminopyridine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02280096
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-02
- **Final completion:** 2017-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280096, "Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02280096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*